Logo

Some Drugs and Herbal Products

Small book cover: Some Drugs and Herbal Products

Some Drugs and Herbal Products

Publisher: International Agency for Research on Cancer
Number of pages: 438

Description:
This volume of the IARC Monographs provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin (widely prescribed for the treatment of chronic heart failure), pioglitazone (used for the treatment of type 2 diabetes mellitus), and hydrochlorothiazide (used to treat hypertension).

Home page url

Download or read it online for free here:
Download link
(8.7MB, PDF)

Similar books

Book cover: Comparative OncologyComparative Oncology
by - Romanian Academy
Comparative oncology has undergone a special development over the past decades and has attracted the interest of researchers who have studied the etiopathogenesis, morphogenesis and epidemiology, as well as the carcinogens of tumor disease.
(12442 views)
Book cover: Cancer BiomarkersCancer Biomarkers
by - National Academies Press
Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured. There is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches.
(14853 views)
Book cover: Noninvasive Diagnostic Techniques for the Detection of Skin CancersNoninvasive Diagnostic Techniques for the Detection of Skin Cancers
by - Agency for Healthcare Research and Quality
The book provides a description of noninvasive imaging modalities in diagnosing cancerous tumors of the skin, proffers an analytic framework for assessing the applications of the imaging modalities, and summarizes the state of ongoing research.
(9127 views)
Book cover: Genetic Susceptibility to Breast and Ovarian CancerGenetic Susceptibility to Breast and Ovarian Cancer
- American College of Medical Genetics
The Guidelines have been prepared to help the primary care provider to participate in the pre- and post-test education and counseling required for every patient contemplating genetic testing for breast and ovarian cancer.
(9583 views)